Adia Med Reports No Serious Adverse Events in First Cohort of Pediatric Autism Study; Enrollment ContinuesNewsfile Corp · 3 hr ago
Adia Med Sells 7% Economic Interest in Adia Labs to CEO Larry Powalisz for $350,000 in CashNewsfile Corp · 6 days ago
Adia Med Fully Repays Related-Party Credit Facility, Strengthening Its Financial PositionNewsfile Corp · Oct 13, 2026
Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 MillionNewsfile Corp · Oct 6, 2026
Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product LineNewsfile Corp · Sep 29, 2026
Adia Med Inc. Announces Adia Labs Biologic Inventory Now Exceeds $1.5 Million to Meet Rising Demand for the Company's Biological ProductsNewsfile Corp · Sep 22, 2026Adia Med Inc. is a publicly traded company dedicated to advancing regenerative medicine and healthcare innovation. The company operates through its primary divisions: Adia Med clinics and Adia Labs LLC. Adia Med clinics deliver specialized regenerative treatments, including stem cell therapies, while Adia Labs manufactures and distributes regenerative products.